Literature DB >> 10741846

Volunteer bias in nonrandomized evaluations of the efficacy of needle-exchange programs.

H Hagan1, J P McGough, H Thiede, S G Hopkins, N S Weiss, E R Alexander.   

Abstract

OBJECTIVE: Nonrandomized comparisons of the incidence of HIV and hepatitis B and C between injection drug users (IDUs) who do and do not attend voluntary needle-exchange programs may be subject to bias. To explore possible sources of bias, we examined characteristics associated with voluntarily beginning or ceasing to participate in the Seattle needle exchange.
METHODS: In a cohort of 2,879 IDUs, a standardized questionnaire measured characteristics present at enrollment. We examined the relation of these characteristics to the proportion of IDUs who began to use the program during the ensuing 12-month follow-up period and to the proportion of current exchangers who dropped out during that period of time.
RESULTS: Of the 494 never-exchangers at baseline, 32% attended the exchange program during follow-up; those who reported sharing syringes or who were homeless at enrollment were more likely to become new exchange users (adjusted risk ratio [ARR] for becoming an exchange user = 1.8 for those who shared syringes, and ARR = 2.2 for those who were homeless). Of 1,274 current exchangers, 16% stopped using the exchange during followup, with daily injectors (ARR = 0.6) and those who reported backloading (ARR = 0.6) being relatively less likely to drop out of the exchange.
CONCLUSIONS: The analysis suggests that IDUs participating in needle-exchange programs at a given point in time may include a particularly high proportion of those injectors whose pattern of drug use puts them at elevated risk of blood-borne viral infections.

Entities:  

Mesh:

Year:  2000        PMID: 10741846      PMCID: PMC3456613          DOI: 10.1007/BF02350966

Source DB:  PubMed          Journal:  J Urban Health        ISSN: 1099-3460            Impact factor:   3.671


  14 in total

1.  Do needle exchange programmes increase the spread of HIV among injection drug users?: an investigation of the Vancouver outbreak.

Authors:  M T Schechter; S A Strathdee; P G Cornelisse; S Currie; D M Patrick; M L Rekart; M V O'Shaughnessy
Journal:  AIDS       Date:  1999-04-16       Impact factor: 4.177

2.  Needle exchange is not enough: lessons from the Vancouver injecting drug use study.

Authors:  S A Strathdee; D M Patrick; S L Currie; P G Cornelisse; M L Rekart; J S Montaner; M T Schechter; M V O'Shaughnessy
Journal:  AIDS       Date:  1997-07       Impact factor: 4.177

3.  Reductions in high-risk drug use behaviors among participants in the Baltimore needle exchange program.

Authors:  D Vlahov; B Junge; R Brookmeyer; S Cohn; E Riley; H Armenian; P Beilenson
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1997-12-15

Review 4.  Syringe-exchange programmes for injecting drug users.

Authors:  G V Stimson
Journal:  AIDS       Date:  1989-05       Impact factor: 4.177

5.  Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program.

Authors:  H Hagan; D C Jarlais; S R Friedman; D Purchase; M J Alter
Journal:  Am J Public Health       Date:  1995-11       Impact factor: 9.308

6.  An interview study of participants in the Tacoma, Washington, syringe exchange.

Authors:  H Hagan; D C Des Jarlais; D Purchase; S R Friedman; T Reid; T A Bell
Journal:  Addiction       Date:  1993-12       Impact factor: 6.526

7.  The effect of misclassification in the presence of covariates.

Authors:  S Greenland
Journal:  Am J Epidemiol       Date:  1980-10       Impact factor: 4.897

8.  Who uses needle exchange? A study of injection drug users in treatment in San Francisco, 1989-1990.

Authors:  J A Hahn; K M Vranizan; A R Moss
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1997-06-01

9.  HIV incidence among injecting drug users in New York City syringe-exchange programmes.

Authors:  D C Des Jarlais; M Marmor; D Paone; S Titus; Q Shi; T Perlis; B Jose; S R Friedman
Journal:  Lancet       Date:  1996-10-12       Impact factor: 79.321

10.  Syringe exchange and risk of infection with hepatitis B and C viruses.

Authors:  H Hagan; J P McGough; H Thiede; N S Weiss; S Hopkins; E R Alexander
Journal:  Am J Epidemiol       Date:  1999-02-01       Impact factor: 4.897

View more
  18 in total

1.  Selection effect of needle exchange in Anchorage, Alaska.

Authors:  Dennis G Fisher; Grace L Reynolds; Colin R Harbke
Journal:  J Urban Health       Date:  2002-03       Impact factor: 3.671

2.  Changes in injection risk behavior associated with participation in the Seattle needle-exchange program.

Authors:  H Hagan; H Thiede
Journal:  J Urban Health       Date:  2000-09       Impact factor: 3.671

3.  Cessation of injecting drug use among street-based youth.

Authors:  Colin Steensma; Jean-François Boivin; Lucie Blais; Elise Roy
Journal:  J Urban Health       Date:  2005-09-29       Impact factor: 3.671

4.  Treatment readiness, attitudes toward, and experiences with methadone and buprenorphine maintenance therapy among people who inject drugs in Malaysia.

Authors:  Aishwarya Vijay; Alexander R Bazazi; Ilias Yee; Adeeba Kamarulzaman; Frederick L Altice
Journal:  J Subst Abuse Treat       Date:  2015-02-18

Review 5.  A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs.

Authors:  Holly Hagan; Enrique R Pouget; Don C Des Jarlais
Journal:  J Infect Dis       Date:  2011-07-01       Impact factor: 5.226

Review 6.  Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs.

Authors:  Lucy Platt; Silvia Minozzi; Jennifer Reed; Peter Vickerman; Holly Hagan; Clare French; Ashly Jordan; Louisa Degenhardt; Vivian Hope; Sharon Hutchinson; Lisa Maher; Norah Palmateer; Avril Taylor; Julie Bruneau; Matthew Hickman
Journal:  Cochrane Database Syst Rev       Date:  2017-09-18

7.  Drug injection rates and needle-exchange use in New York City, 1991-1996.

Authors:  M Marmor; R E Shore; S Titus; X Chen; D C Des Jarlais
Journal:  J Urban Health       Date:  2000-09       Impact factor: 3.671

8.  Greater drug injecting risk for HIV, HBV, and HCV infection in a city where syringe exchange and pharmacy syringe distribution are illegal.

Authors:  Alan Neaigus; Mingfang Zhao; V Anna Gyarmathy; Linda Cisek; Samuel R Friedman; Robert C Baxter
Journal:  J Urban Health       Date:  2008-03-14       Impact factor: 3.671

Review 9.  Recent advances in the treatment of opiate addiction.

Authors:  Paul J Fudala; George W Woody
Journal:  Curr Psychiatry Rep       Date:  2004-10       Impact factor: 5.285

10.  High prevalence of latent tuberculosis infection among injection drug users in Tijuana, Mexico.

Authors:  R S Garfein; R Lozada; L Liu; R Laniado-Laborin; T C Rodwell; R Deiss; J Alvelais; A Catanzaro; P G Chiles; S A Strathdee
Journal:  Int J Tuberc Lung Dis       Date:  2009-05       Impact factor: 2.373

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.